Company intelligence / Profile preview

Adelphi FocusRx

Bollington/Macclesfield area, Greater Manchester, United Kingdom6sense.com ↗

Ownership: Private
Development stage: Other

Overview

Adelphi FocusRx is a division within the broader Adelphi Group, specializing in pharmaceutical consultancy and service provision. The group offers services spanning the lifecycle of pharmaceutical development, including strategic product development consultancy, health economics and outcomes research, real-world disease understanding, marketing research, medical communications, and post-meeting brand support services. They do not develop therapeutics themselves but provide critical support to life science companies throughout product development and commercialization phases.

Therapeutic areas: Other
Modalities: Not applicable
Industry: Consulting

Beyond the preview

Go deeper on Adelphi FocusRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adelphi FocusRx.

Explore the full profile